Literature DB >> 18349856

Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors?

Peter Hohenberger1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349856     DOI: 10.1038/ncponc1091

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


× No keyword cloud information.
  2 in total

1.  Rare anorectal neoplasms: gastrointestinal stromal tumor, carcinoid, and lymphoma.

Authors:  Elizabeth A Peralta
Journal:  Clin Colon Rectal Surg       Date:  2009-05

Review 2.  Imatinib: as adjuvant therapy for gastrointestinal stromal tumour.

Authors:  Mark Sanford; Lesley J Scott
Journal:  Drugs       Date:  2010-10-22       Impact factor: 11.431

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.